Literature DB >> 34037423

An Amino Acid Polymorphism within the HIV-1 Nef Dileucine Motif Functionally Uncouples Cell Surface CD4 and SERINC5 Downregulation.

Mitchell J Mumby1, Aaron L Johnson1, Steven M Trothen1, Cassandra R Edgar1, Richard Gibson1, Peter B Stathopulos2, Eric J Arts1,3, Jimmy D Dikeakos1.   

Abstract

Serine incorporator 5 (SERINC5) reduces the infectivity of progeny HIV-1 virions by incorporating into the outer host-derived viral membrane during egress. To counter SERINC5, the HIV-1 accessory protein Nef triggers SERINC5 internalization by engaging the adaptor protein 2 (AP-2) complex using the [D/E]xxxL[L/I]167 Nef dileucine motif. Nef also engages AP-2 via its dileucine motif to downregulate the CD4 receptor. Although these two Nef functions are related, the mechanisms governing SERINC5 downregulation are incompletely understood. Here, we demonstrate that two primary Nef isolates, referred to as 2410 and 2391 Nef, acquired from acutely HIV-1 infected women from Zimbabwe, both downregulate CD4 from the cell surface. However, only 2410 Nef retains the ability to downregulate cell surface SERINC5. Using a series of Nef chimeras, we mapped the region of 2391 Nef responsible for the functional uncoupling of these two antagonistic pathways to the dileucine motif. Modifications of the first and second x positions of the 2410 Nef dileucine motif to asparagine and aspartic acid residues, respectively (ND164), impaired cell surface SERINC5 downregulation, which resulted in reduced infectious virus yield in the presence of SERINC5. The ND164 mutation additionally partially impaired, but did not completely abrogate, Nef-mediated cell surface CD4 downregulation. Furthermore, the patient infected with HIV-1 encoding 2391 Nef had stable CD4+ T cell counts, whereas infection with HIV-1 encoding 2410 Nef resulted in CD4+ T cell decline and disease progression. IMPORTANCE A contributing factor to HIV-1 persistence is evasion of the host immune response. HIV-1 uses the Nef accessory protein to evade the antiviral roles of the adaptive and intrinsic innate immune responses. Nef targets SERINC5, a restriction factor which potently impairs HIV-1 infection by triggering SERINC5 removal from the cell surface. The molecular determinants underlying this Nef function remain incompletely understood. Recent studies have found a correlation between the extent of Nef-mediated SERINC5 downregulation and the rate of disease progression. Furthermore, single-residue polymorphisms outside the known Nef functional motifs can modulate SERINC5 downregulation. The identification of a naturally occurring Nef polymorphism impairing SERINC5 downregulation in this study supports a link between Nef downregulation of SERINC5 and the rate of plasma CD4+ T cell decline. Moreover, the observed functional impairments of this polymorphism could provide clues to further elucidate unknown aspects of the SERINC5 antagonistic pathway via Nef.

Entities:  

Keywords:  CD4; HIV; Nef; SERINC5; infectivity; membrane trafficking

Mesh:

Substances:

Year:  2021        PMID: 34037423      PMCID: PMC8312866          DOI: 10.1128/JVI.00588-21

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  A diacidic motif in human immunodeficiency virus type 1 Nef is a novel determinant of binding to AP-2.

Authors:  O Wolf Lindwasser; William J Smith; Rittik Chaudhuri; Peter Yang; James H Hurley; Juan S Bonifacino
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

2.  The gamma/sigma1 and alpha/sigma2 hemicomplexes of clathrin adaptors AP-1 and AP-2 harbor the dileucine recognition site.

Authors:  Balraj Doray; Intaek Lee; Jane Knisely; Guojun Bu; Stuart Kornfeld
Journal:  Mol Biol Cell       Date:  2007-03-14       Impact factor: 4.138

3.  Interaction of HIV-1 Nef with the cellular dileucine-based sorting pathway is required for CD4 down-regulation and optimal viral infectivity.

Authors:  H M Craig; M W Pandori; J C Guatelli
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

4.  The interaction between HIV-1 Nef and adaptor protein-2 reduces Nef-mediated CD4+ T cell apoptosis.

Authors:  Rajesh Abraham Jacob; Aaron L Johnson; Emily N Pawlak; Brennan S Dirk; Logan R Van Nynatten; S M Mansour Haeryfar; Jimmy D Dikeakos
Journal:  Virology       Date:  2017-06-01       Impact factor: 3.616

5.  Nef homodimers down-regulate SERINC5 by AP-2-mediated endocytosis to promote HIV-1 infectivity.

Authors:  Ryan P Staudt; Thomas E Smithgall
Journal:  J Biol Chem       Date:  2020-09-01       Impact factor: 5.157

6.  A computer program designed to screen rapidly for HIV type 1 intersubtype recombinant sequences.

Authors:  A C Siepel; A L Halpern; C Macken; B T Korber
Journal:  AIDS Res Hum Retroviruses       Date:  1995-11       Impact factor: 2.205

7.  CD4 downregulation by the HIV-1 protein Nef reveals distinct roles for the γ1 and γ2 subunits of the AP-1 complex in protein trafficking.

Authors:  Lucas A Tavares; Eulália M L da Silva; Mara E da Silva-Januário; Yunan C Januário; Julianne V de Cavalho; Érika S Czernisz; Gonzalo A Mardones; Luis L P daSilva
Journal:  J Cell Sci       Date:  2016-12-01       Impact factor: 5.285

8.  CD4 and major histocompatibility complex class I downregulation by the human immunodeficiency virus type 1 nef protein in pediatric AIDS progression.

Authors:  Nicoletta Casartelli; Gigliola Di Matteo; Marina Potestà; Paolo Rossi; Margherita Doria
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

9.  A Transmembrane Domain GGxxG Motif in CD4 Contributes to Its Lck-Independent Function but Does Not Mediate CD4 Dimerization.

Authors:  Heather L Parrish; Caleb R Glassman; Madeline M Keenen; Neha R Deshpande; Matthew P Bronnimann; Michael S Kuhns
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

10.  Variation in HIV-1 Nef function within and among viral subtypes reveals genetically separable antagonism of SERINC3 and SERINC5.

Authors:  Steven W Jin; Francis M Mwimanzi; Jaclyn K Mann; Mwebesa Bosco Bwana; Guinevere Q Lee; Chanson J Brumme; Peter W Hunt; Jeff N Martin; David R Bangsberg; Thumbi Ndung'u; Zabrina L Brumme; Mark A Brockman
Journal:  PLoS Pathog       Date:  2020-09-14       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.